Teladoc Q3 revenue $640.5M (-3% YoY), net loss narrows to $0.19 EPS; BetterHelp revenue down 10%

Teladoc Health, Inc.

2024-Q3 EPS reported -$5.61 revenue$1,929,083,000

Revenue $640.5M (-3% YoY); net loss $33.3M ($0.19 per share) vs $57.1M loss last year.
Adjusted EBITDA $83.3M (-6% YoY); Integrated Care margin 17.7%, BetterHelp margin 5.9%.
BetterHelp revenue down 10% to $256.8M; nine-month goodwill impairment of $790M recorded.
Free cash flow $79.0M in Q3 vs $68.0M YoY; operating cash flow $110.2M.
Guidance: Integrated Care Q4 revenue growth 0-2.5%, FY24 adj. EBITDA margin ~15%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.